A Study to Evaluate the Efficacy of MuGard for the Amelioration of Oral Mucositis in Head and Neck Cancer Patients

NCT01283906 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Oral Mucositis

Interventions

DEVICE: MuGard
DEVICE: Control Rinse

Sponsor

Access Pharmaceuticals, Inc.